Relationship between circulating platelet counts and ductus arteriosus patency after indomethacin treatment

J Pediatr. 2011 Jun;158(6):919-923.e1-2. doi: 10.1016/j.jpeds.2010.11.018. Epub 2010 Dec 30.

Abstract

Objective: To determine whether low platelet counts are related to the incidence of patent ductus arteriosus (PDA) after indomethacin treatment in preterm human infants.

Study design: Multivariable logistic regression modeling was used for a cohort of 497 infants, who received indomethacin (within 15 hours of birth).

Results: Platelet counts were not related to the incidence of permanent closure after indomethacin constriction. There was a relationship between platelet counts and the initial degree of constriction; however, this relationship appeared to be primarily influenced by the high end of the platelet distribution curve. PDA incidence was similar in infants with platelet counts < 50 × 10⁹/L and those with platelet counts above this range. Only when platelet counts were consistently >230 ×10⁹/L was there a decrease in PDA incidence.

Conclusion: In contrast to the evidence in mice, low circulating platelet counts do not affect permanent ductus closure (or ductus reopening) in human preterm infants.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiovascular Agents / pharmacology*
  • Cohort Studies
  • Ductus Arteriosus / drug effects
  • Ductus Arteriosus, Patent / blood*
  • Ductus Arteriosus, Patent / drug therapy*
  • Echocardiography / methods
  • Female
  • Humans
  • Indomethacin / pharmacology*
  • Infant, Newborn
  • Infant, Premature
  • Male
  • Platelet Count*
  • Regression Analysis
  • Time Factors
  • Treatment Outcome

Substances

  • Cardiovascular Agents
  • Indomethacin